stage III colorectal cancer
The Survival Impact of Fluoropyrimidine Metronomic Maintenance Therapy Following Adjuvant Oxaliplatin-based Chemotherapy in Patients with Stage III Colorectal Cancer after Radical Resection: Functional Roles of EGFR as a Potential Predictor
23
Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients
18
Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery
9
Comparing survival and recurrence in curative stage I to stage III colorectal cancer in transfused and nontransfused patients
9
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
17
Predictive Values of EGFR Expression for the
18
The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)
10
Original Article CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression
10
Original Article Prognostic significance of stromal SMYD3 expression in colorectal cancer of TNM stage I-III
7
Major postoperative complications and survival for colon cancer elderly patients
5
Original Article Clinical significance of long non-coding RNA ZEB2-AS1 in locally advanced colorectal cancer
6
Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases
8
Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I-III patients with colorectal cancer after operation
14
A cohort study of metformin exposure and survival in patients with stage I III colorectal cancer
11
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
6
Identification and characterization of ANO9 in stage II and III colorectal carcinoma
11
Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
8
Benefits of Pre-Operative Concurrent Chemo- Radiotherapy among Elder Patients with Local Advanced Rectal Cancer Ting and Yeh
13
Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010
10
Colonoscopy a True Therapeutic Icon
12